Trial intelligence / Profile preview

Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

NCT00672633Phase 2Terminated

Sponsor
Boston Children's Hospital
Start
Apr 2008
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by Boston Children's Hospital. Started Apr 2008; status: terminated.

02

Drugs

eicosapentaenoic acid + docosahexaenoic acid
03

Conditions

hypertriglyceridemia

Beyond the preview

Go deeper on NCT00672633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00672633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call